Health Catalyst, Inc. (NASDAQ:HCAT) Receives $11.50 Average Target Price from Analysts

Health Catalyst, Inc. (NASDAQ:HCAT) has received an average recommendation of “Moderate Buy” from the twelve research firms that are covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $11.50.

Several analysts recently commented on the company. Stephens dropped their price objective on Health Catalyst from $8.00 to $7.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 8th. Cantor Fitzgerald reissued an “overweight” rating and issued a $16.00 price target on shares of Health Catalyst in a research note on Tuesday. Canaccord Genuity Group reissued a “buy” rating and issued a $11.00 price target on shares of Health Catalyst in a research note on Tuesday, May 21st. Piper Sandler dropped their price target on Health Catalyst from $15.00 to $14.00 and set an “overweight” rating on the stock in a research note on Thursday, June 6th. Finally, Wells Fargo & Company dropped their price target on Health Catalyst from $14.00 to $13.00 and set an “overweight” rating on the stock in a research note on Friday, May 10th.

Health Catalyst Stock Up 3.0 %

NASDAQ:HCAT opened at $7.27 on Friday. The firm has a market capitalization of $429.18 million, a P/E ratio of -3.93 and a beta of 1.32. Health Catalyst has a 12-month low of $5.42 and a 12-month high of $12.05. The stock’s fifty day simple moving average is $6.67 and its 200-day simple moving average is $7.11.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.12 EPS for the quarter, topping the consensus estimate of $0.08 by $0.04. The business had revenue of $75.90 million for the quarter, compared to the consensus estimate of $74.96 million. Health Catalyst had a negative return on equity of 11.86% and a negative net margin of 35.56%. The firm’s revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the business posted ($0.21) EPS. As a group, equities research analysts expect that Health Catalyst will post -0.4 earnings per share for the current year.

Insider Buying and Selling

In related news, COO Daniel Lesueur sold 5,209 shares of the company’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $6.19, for a total transaction of $32,243.71. Following the sale, the chief operating officer now owns 150,006 shares in the company, valued at $928,537.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last quarter, insiders have sold 13,035 shares of company stock worth $81,396. Corporate insiders own 2.70% of the company’s stock.

Hedge Funds Weigh In On Health Catalyst

Institutional investors have recently bought and sold shares of the business. Nisa Investment Advisors LLC increased its position in Health Catalyst by 461.0% during the second quarter. Nisa Investment Advisors LLC now owns 6,367 shares of the company’s stock worth $41,000 after buying an additional 5,232 shares during the last quarter. Quarry LP increased its position in Health Catalyst by 59.4% during the second quarter. Quarry LP now owns 7,002 shares of the company’s stock worth $45,000 after buying an additional 2,610 shares during the last quarter. Perfromance Wealth Partners LLC acquired a new position in Health Catalyst during the second quarter worth approximately $64,000. Mackenzie Financial Corp acquired a new position in Health Catalyst during the second quarter worth approximately $70,000. Finally, Los Angeles Capital Management LLC acquired a new position in Health Catalyst during the fourth quarter worth approximately $108,000. Institutional investors and hedge funds own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.